Literature DB >> 17985091

Gastrinoma--morphological aspects.

Günter Klöppel1, Martin Anlauf.   

Abstract

Gastrinomas are defined as gastrin producing tumors that are associated with an elevated fasting gastrin serum level, a positive gastrin secretin stimulation test and certain clinical symptoms, e.g. recurrent peptic ulcer disease and occasionally diarrhea, the so-called Zollinger-Ellison syndrome. Most gastrinomas occur in the duodenum (approx. 70%) and not in the pancreas. The duodenal gastrinomas are small, and when they occur in association with the genetic syndrome of multiple endocrine neoplasia type 1 (MEN1), they are multicentric and originate from precursor lesions. The prognosis of duodenal gastrinomas is better than that of pancreatic gastrinomas, since despite early lymph node metastasis they progress slowly to liver metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17985091     DOI: 10.1007/s00508-007-0885-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   2.275


  36 in total

1.  SURGICAL CONSIDERATION IN THE MANAGEMENT OF ULCEROGENIC TUMORS OF THE PANCREAS AND DUODENUM.

Authors:  H A OBERHELMAN; T S NELSEN
Journal:  Am J Surg       Date:  1964-08       Impact factor: 2.565

2.  Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.

Authors:  R M ZOLLINGER; E H ELLISON
Journal:  Ann Surg       Date:  1955-10       Impact factor: 12.969

3.  Pancreatic-polypeptide cell hyperplasia associated with pancreatic or duodenal gastrinomas.

Authors:  E M Martella; G Ferraro; C Azzoni; M Marignani; C Bordi
Journal:  Hum Pathol       Date:  1997-02       Impact factor: 3.466

4.  Zollinger-Ellison syndrome. Cure by surgical resection of a jejunal gastrinoma containing growth hormone releasing factor.

Authors:  D A Antonioli; Y Dayal; A M Dvorak; P A Banks
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

Review 5.  Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.

Authors:  M Pipeleers-Marichal; C Donow; P U Heitz; G Klöppel
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

6.  Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings.

Authors:  T D'Adda; V Corleto; F P Pilato; M T Baggi; F Robutti; G Delle Fave; C Bordi
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

7.  Pancreatic endocrine tumors.

Authors:  P U Heitz; M Kasper; J M Polak; G Klöppel
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

8.  The gastrinoma triangle: operative implications.

Authors:  B E Stabile; D J Morrow; E Passaro
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

Review 9.  Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.

Authors:  E Solcia; C Capella; R Fiocca; G Rindi; J Rosai
Journal:  Am J Surg Pathol       Date:  1990-06       Impact factor: 6.394

10.  Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.

Authors:  M Pipeleers-Marichal; G Somers; G Willems; A Foulis; C Imrie; A E Bishop; J M Polak; W H Häcki; B Stamm; P U Heitz
Journal:  N Engl J Med       Date:  1990-03-15       Impact factor: 91.245

View more
  17 in total

1.  [A young man with chronic diarrhea and epigastric pain].

Authors:  Juliane Buchkremer; Hans-Jörg Epple; Hanno Tröger; Frank Heller; Bernd Frericks; Esther Herpel; Christa Flechtenmacher; Markus Wolfgang Büchler; Martin Zeitz
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Hypergastrinemia--diagnosis and treatment.

Authors:  Bruno Niederle
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

3.  A network map of the gastrin signaling pathway.

Authors:  Yashwanth Subbannayya; Kumari Anuja; Jayshree Advani; Urmesh Kumar Ojha; Vishalakshi Nanjappa; Bijesh George; Avinash Sonawane; Rekha V Kumar; Girija Ramaswamy; Akhilesh Pandey; B L Somani; Rajesh Raju
Journal:  J Cell Commun Signal       Date:  2014-03-02       Impact factor: 5.782

Review 4.  [Pathology of neuroendocrine neoplasms].

Authors:  M Anlauf; P Gerlach; M Schott; A Raffel; M Krausch; W T Knoefel; M Pavel; G Klöppel
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

5.  Lymph nodes metastasis and recurrences justify an aggressive treatment of gastrinoma.

Authors:  Francesco Giovinazzo; Giovanni Butturini; Daniela Monsellato; Giuseppe Malleo; Giovanni Marchegiani; Claudio Bassi
Journal:  Updates Surg       Date:  2013-02-16

6.  Conditional deletion of menin results in antral G cell hyperplasia and hypergastrinemia.

Authors:  Natalia A Veniaminova; Michael M Hayes; Jessica M Varney; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-05       Impact factor: 4.052

Review 7.  Practical management and treatment of pancreatic neuroendocrine tumors.

Authors:  Naoko Iwahashi Kondo; Yasuharu Ikeda
Journal:  Gland Surg       Date:  2014-11

Review 8.  Zollinger-Ellison syndrome: recent advances and controversies.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

9.  Cytopathological evaluation of potential malignancy of duodenal gastrinoma using aspiration smears from two patients' resected tumors (NET G1, NET G2): A case report.

Authors:  Hirotaka Noda; Kazuyoshi Masuda; Masami Kanbara; Hiromi Maeda; Tadao K Kobayashi; Chikao Yutani
Journal:  Mol Clin Oncol       Date:  2020-04-10

10.  Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1).

Authors:  Ursula Plöckinger
Journal:  Cancers (Basel)       Date:  2012-01-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.